EZ Debride, out of San Antonio and Kernville, Texas, signed a distribution agreement with Intega Healthcare, Singapore, according to a press release.
Intega Healthcare is a specialist healthcare, medical devices and services company in Singapore that offers first-class treatment to more than 650 million people in the Association of Southeast Asian Nations.
"At Intega Healthcare, we are excited to partner with MDM Ventures to introduce EZ Debride to our customers," Rebecca Ng, Business Development and Operations director at Intega Healthcare, said in a press release. "EZ Debride is an innovative product that will offer clinicians an option to safely remove non-viable tissues with precision and minimal discomfort for patients. EZ Debride complements our innovative wound care portfolio that comprises cellular therapy and regenerative tissue treatments, advanced wound care, surgical, and wound closure range. The partnership with MDM is allowing us to offer our clinicians a complete set of products and services which expands their patient treatment options."
A patented brand of MDM Wound Ventures Inc., EZ Debride is a simple, sharp debridement instrument, allowing clinicians with little or no prior experience to precisely remove damaged tissue or foreign objects from a wound.
"Partnering with Intega Healthcare allows EZ Debride's availability into Southeast Asia, which is very important to our mission and growth. Their well-established team will distribute EZ Debride in the ASEAN region. We are excited to have a partner in this important region." Derek T. Denton, CEO, MDM Wound Ventures, Inc. said in a press release.
EZ Debride also plans to expand to Canada, the Asia-Pacific region, the Middle East, as well as other countries and territories.